Primary Hyperaldosteronism in Clinical Practice

Authors

  • Gulrukh Alimoukhamedova DSc, Leading Scientific Assistant, Department of Neuroendocrinology with the pituitary surgery, Academician Yo. Kh. Turakulov Center for the Scientific and Clinical Study of Endocrinology, Uzbekistan Public Healthcare Ministry, Tashkent,
  • Zamira Khalimova DSc, professor, Head of the scientific Department of Neuroendocrinology with the pituitary surgery, Academician Yo. Kh. Turakulov Center for the Scientific and Clinical Study of Endocrinology, Uzbekistan Public Healthcare Ministry, Tashkent

Keywords:

adrenal tumors, arterial hypertension, primary aldosteronism.

Abstract

The data obtained in the study of the clinical features of aldosterone-producing adrenal adenomas indicate that aldosteromas are more common in young working age (the average age of patients was 42.4 ± 12.4 years old, and the peak incidence was at the age of 18 to 44 years old) with a predominance among females. The classical clinical triad, which includes a combination of three main syndromes (AH, neuromuscular and renal), was found only in 62.5% of the patients. The leading clinical manifestation in all the patients with aldosteroma in 100% of the cases was hypertension, which was permanent in 75% of the patients, mixed in 12.5%, while constant malignant hypertension was observed in 12.5% of the cases. At the same time, stage 1 (50%) and stage 2 hypertension (37.5%) were registered most often in patients with aldosterone-producing adenomas, and only stage 3 hypertension was registered in 12.5%. It should be noted that the combination of hypertension, especially in young people, and a burdened family history of hypertension and its complications among the relatives of the first line kinship should serve the basis for excluding aldosterone-producing adrenal adenomas.

Downloads

Published

2023-06-12

Issue

Section

Articles